Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial (TAVI-PCI)
Sponsor: University of Zurich
This NA trial investigates Aortic Stenosis and Coronary Artery Disease and is currently ongoing. University of Zurich leads this study, which shows 12 recorded versions since 2020 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
12 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2025 — Oct 2025 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Nov 2021 — Jan 2024 [monthly]
Recruiting NA
-
Oct 2021 — Nov 2021 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2020 — Nov 2020 [monthly]
Not Yet Recruiting NA
-
May 2020 — Jun 2020 [monthly]
Not Yet Recruiting NA
-
Apr 2020 — May 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Zurich
For direct contact, visit the study record on ClinicalTrials.gov .